US Map / Nebraska
State NE

Clinical Trials in Nebraska

Recruiting clinical trials with at least one study location in Nebraska. Data updated daily from ClinicalTrials.gov.

Total Trials
108
Recruiting Now
108
← Back to US Map
Top Conditions in Nebraska
Malignant Solid Neoplasm (4)Prostate Cancer (3)Breast Cancer (3)Heart Failure (3)Glioma (3)Melanoma (2)Acute Treatment of Migraine (2)Hematopoietic and Lymphatic System Neoplasm (2)Acute Myeloid Leukemia (2)Prostatic Neoplasms (2)Pulmonary Hypertension (2)Metastatic Urothelial Cancer (2)
NCT05543616 Phase 2, Phase 3
Recruiting
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Heal...
Condition
SARS-CoV-2 Virus
Enrollment
4,292 pts
Location
United States, Brazil, Puerto Rico
Sponsor
BioNTech SE
View Trial →
NCT04640584 N/A
Recruiting
C-Brace Prospective Registry
Condition
Pareses
Enrollment
250 pts
Location
United States, Australia, Germany
Sponsor
Otto Bock Healthcare Products
View Trial →
NCT05139017 Phase 2, Phase 3
Recruiting
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care i...
Condition
DLBCL
Enrollment
290 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT06339008 Phase 3
Recruiting
A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (...
Condition
Perennial Allergic Rhinitis (PAR)
Enrollment
450 pts
Location
United States, Belgium, China
Sponsor
Eli Lilly and Company
View Trial →
NCT06904274 Phase 3
Recruiting
Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 Months
Condition
Endometrial Hyperplasia
Enrollment
207 pts
Location
United States, Canada, China
Sponsor
Bayer
View Trial →
NCT02708134 N/A
Recruiting
Quality of Pediatric Resuscitation in a Multicenter Collaborative
Condition
Cardiac Arrest
Enrollment
7,000 pts
Location
United States, Australia, Brazil
Sponsor
Children's Hospital of Philade
View Trial →
NCT06592924 Phase 3
Recruiting
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Ca...
Condition
Prostate Cancer (Adenocarcinoma)
Enrollment
830 pts
Location
United States, Canada
Sponsor
Canadian Cancer Trials Group
View Trial →
NCT05983250 Phase 3
Recruiting
LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF
Condition
Pulmonary Hypertension
Enrollment
230 pts
Location
United States, Canada
Sponsor
Tenax Therapeutics, Inc.
View Trial →
Page 5 of 5 — 108 trials total
← Prev